Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Tumor response")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 99

  • Page / 4
Export

Selection :

  • and

Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)CHAREHBILI, A; VAN DE VEN, S; PEPELS, M. J et al.Annals of oncology. 2014, Vol 25, Num 5, pp 998-1004, issn 0923-7534, 7 p.Article

Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian CancerODUNSI, Kunle; MATSUZAKI, Junko; BECK, Amy et al.Cancer immunology research (Print). 2014, Vol 2, Num 1, pp 37-49, issn 2326-6066, 13 p.Article

Survival Prediction in Everolimus-treated Patients with Metastatic Renal Cell Carcinoma Incorporating Tumor Burden Response in the RECORD-1 TrialSTEIN, Andrew; BELLMUNT, Joaquim; ESCUDIER, Bernard et al.European urology. 2013, Vol 64, Num 6, pp 994-1002, issn 0302-2838, 9 p.Article

The in situ local immune response, tumour senescence and proliferation in colorectal cancerROXBURGH, C. S; RICHARDS, C. H; MACDONALD, A. I et al.British journal of cancer. 2013, Vol 109, Num 8, pp 2207-2216, issn 0007-0920, 10 p.Article

Gefitinib is of more benefit in chemotherapy-naive patients with good performance status and adenocarcinoma histology : Retrospective analysis of 575 Korean patientsDAE HO LEE; HAN, Ji-Youn; HEUNG TAE KIM et al.Lung cancer. 2006, Vol 53, Num 3, pp 339-345, issn 0169-5002, 7 p.Article

A phase I/II study of pemetrexed and vinorelbine in patients with non-small cell lung cancerCLARKE, Stephen J; BOYER, Michael J; SURI, Ajit et al.Lung cancer. 2005, Vol 49, Num 3, pp 401-412, issn 0169-5002, 12 p.Article

Pulmonary function following high-dose radiotherapy of non-small-cell lung cancerDE JAEGER, Katrien; SEPPENWOOLDE, Yvette; BOERSMA, Liesbeth J et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 5, pp 1331-1340, issn 0360-3016, 10 p.Article

Anti-PD1 Following Ipilimumab for Mucosal Melanoma: Durable Tumor Response Associated with Severe Hypothyroidism and RhabdomyolysisLE MIN; HODI, F. Stephen.Cancer immunology research (Print). 2014, Vol 2, Num 1, pp 15-18, issn 2326-6066, 4 p.Article

Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabinePAPADEMETRIO, Daniela Laura; CAVALIERE, Victoria; SIMUNOVICH, Tania et al.Targeted oncology. 2014, Vol 9, Num 2, pp 123-134, issn 1776-2596, 12 p.Article

La réduction des volumes ou l'intensité de la réponse tumorale en cancérologie colorectale = The Reduction in Volume or Intensity of Tumour Response in Colorectal OncologyPHELIP, J.-M; BOUARIOUA, N; TATU, A et al.Oncologie (Paris). 2014, Vol 16, Num 11-12, pp 587-592, issn 1292-3818, 6 p.Article

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRIBELOUECHE-BABARI, M; JAMIN, Y; LEACH, M. O et al.British journal of cancer. 2013, Vol 109, Num 6, pp 1562-1569, issn 0007-0920, 8 p.Article

Formation and repair kinetics of Pt-(GpG) DNA adducts in extracted circulating tumour cells and response to platinum treatmentNEL, I; GAULER, T. C; EBERHARDT, W. E et al.British journal of cancer. 2013, Vol 109, Num 5, pp 1223-1229, issn 0007-0920, 7 p.Article

Telomere dysfunction and tumor suppression responses in dyskeratosis congenita: Balancing cancer and tissue renewal impairmentHARTWIG, Fernando Pires; COLLARES, Tiago.Ageing research reviews. 2013, Vol 12, Num 2, pp 642-652, issn 1568-1637, 11 p.Article

Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted TherapySMITH, Neil R; BAKER, Dawn; WEDGE, Stephen R et al.Clinical cancer research (Print). 2013, Vol 19, Num 24, pp 6943-6956, issn 1078-0432, 14 p.Article

Imagerie fonctionnelle de la réponse aux thérapies ciblées: TDM et IRM = Functional imaging of treatment response: CT and MRIFOURNIER, L. S; AMMARI, S; THIAM, R et al.Correspondances en onco-urologie. 2013, Vol 4, Num 3, pp 106-109, issn 2110-087X, 4 p.Article

A statistical simulation study finds discordance between WHO criteria and RECIST guidelineMAZUMDAR, Madhu; SMITH, Alex; SCHWARTZ, Lawrence H et al.Journal of clinical epidemiology. 2004, Vol 57, Num 4, pp 358-365, issn 0895-4356, 8 p.Article

FoxO Transcription Factors Promote AKT Ser473 Phosphorylation and Renal Tumor Growth in Response to Pharmacologic Inhibition of the PI3K-AKT PathwayAIFU LIN; PIAO, Hai-Long; LI ZHUANG et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 6, pp 1682-1693, issn 0008-5472, 12 p.Article

Mechanistic pharmacokinetic/pharmacodynamic modeling of in vivo tumor uptake, catabolism, and tumor response of trastuzumab maytansinoid conjugatesWADA, Russ; ERICKSON, Hans K; LEWIS PHILLIPS, Gail D et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 5, pp 969-980, issn 0344-5704, 12 p.Article

Microvesicle Cargo of Tumor-Associated MUC1 to Dendritic Cells Allows Cross-presentation and Specific Carbohydrate ProcessingRUGHETTI, Aurelia; RAHIMI, Hassan; BURCHELL, Joy M et al.Cancer immunology research (Print). 2014, Vol 2, Num 2, pp 177-186, issn 2326-6066, 10 p.Article

Phase 1 Study of the Antimesothelin Immunotoxin SS1P in Combination With Pemetrexed and Cisplatin for Front-Line Therapy of Pleural Mesothelioma and Correlation of Tumor Response With Serum Mesothelin, Megakaryocyte Potentiating Factor, and Cancer Antigen 125HASSAN, Raffit; SHARON, Elad; THOMAS, Anish et al.Cancer. 2014, Vol 120, Num 21, pp 3311-3319, issn 0008-543X, 9 p.Article

Influence of soluble or matrix-bound isoforms of vascular endothelial growth factor-A on tumor response to vascular-targeted strategiesAKERMAN, Simon; FISHER, Matthew; BARBER, Paul R et al.International journal of cancer (Print). 2013, Vol 133, Num 11, pp 2563-2576, issn 0020-7136, 14 p.Article

Tumour response and safety of cetuximab in a window pre-operative study in patients with squamous cell carcinoma of the head and neckSCHMITZ, S; HAMOIR, M; LONNEUX, M et al.Annals of oncology. 2013, Vol 24, Num 9, pp 2261-2266, issn 0923-7534, 6 p.Article

Qu'apporte la réponse tumorale dans le cancer colorectal ? = What is the contribution of tumor response in colorectal cancer?BACHET, Jean-Baptiste; PAOLETTI, Xavier; FOURNIER, Laure et al.Bulletin du cancer. 2013, Vol 100, Num 7-8, pp 743-755, issn 0007-4551, 13 p.Article

Developing a Common Language for Tumor Response to Immunotherapy: Immune-Related Response Criteria Using Unidimensional MeasurementsNISHINO, Mizuki; GIOBBIE-HURDER, Anita; GARGANO, Maria et al.Clinical cancer research (Print). 2013, Vol 19, Num 14, pp 3936-3943, issn 1078-0432, 8 p.Article

Modeling of mesothelioma growth demonstrates weaknesses of current response criteriaOXNARD, Geoffrey R; ARMATO, Samuel G; KINDLER, Hedy L et al.Lung cancer. 2006, Vol 52, Num 2, pp 141-148, issn 0169-5002, 8 p.Article

  • Page / 4